Free Trial

Urogen Pharma (URGN) Short Interest Ratio & Short Volume

Urogen Pharma logo
$14.26 -0.24 (-1.62%)
As of 10:49 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Urogen Pharma Short Interest Data

Urogen Pharma (URGN) has a short interest of 18.49 million shares, representing 42.26% of the float (the number of shares available for trading by the public). This marks a 201.63% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.1, indicating that it would take 3.1 days of the average trading volume of 1.61 million shares to cover all short positions.

Current Short Interest
18,490,000 shares
Previous Short Interest
6,130,000 shares
Change Vs. Previous Month
+201.63%
Dollar Volume Sold Short
$253.31 million
Short Interest Ratio
3.1 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
46,110,000 shares
Short Percent of Float
42.26%
Today's Trading Volume
117,330 shares
Average Trading Volume
1,610,516 shares
Today's Volume Vs. Average
7%
Short Selling Urogen Pharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Urogen Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

URGN Short Interest Over Time

URGN Days to Cover Over Time

URGN Percentage of Float Shorted Over Time

Urogen Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202518,490,000 shares $253.31 million +201.6%42.3%3.1 $13.70
6/15/20256,130,000 shares $73.74 million +56.4%14.0%2.3 $12.03
5/31/20253,920,000 shares $15.84 million -29.9%17.6%2.3 $4.04
5/15/20255,590,000 shares $55.06 million +11.4%25.1%5.4 $9.85
4/30/20255,020,000 shares $58.43 million -0.8%N/A10 $11.64
4/15/20255,060,000 shares $54.40 million -10.4%22.7%12.2 $10.75
3/31/20255,650,000 shares $62.49 million -8.1%25.4%14.2 $11.06
3/15/20256,150,000 shares $68.08 million +0.5%27.6%15.5 $11.07
2/28/20256,120,000 shares $57.90 million -1.1%27.5%15.7 $9.46
2/15/20256,190,000 shares $66.67 million +0.5%27.8%16.3 $10.77
1/31/20256,160,000 shares $67.82 million +2.8%N/A15.5 $11.01
1/15/20255,990,000 shares $62.24 million +2.7%N/A14.2 $10.39
12/31/20245,830,000 shares $62.09 million +0.3%N/A10.8 $10.65
12/15/20245,810,000 shares $65.94 million +0.7%N/A11.1 $11.35
11/30/20245,770,000 shares $73.28 million -10.4%N/A10.2 $12.70
11/15/20246,440,000 shares $72.06 million -2.4%N/A11.1 $11.19
10/31/20246,600,000 shares $80.92 million +1.7%N/A11 $12.26
10/15/20246,490,000 shares $79.57 million -8.2%N/A11.3 $12.26
9/30/20247,070,000 shares $89.79 million +11.0%N/A13.6 $12.70
9/15/20246,370,000 shares $83.57 million -1.1%N/A12.3 $13.12
8/31/20246,440,000 shares $89.58 million -0.8%N/A9.1 $13.91
8/15/20246,490,000 shares $100.53 million +6.4%N/A9.5 $15.49
7/31/20246,100,000 shares $100.35 million +3.9%N/A9.6 $16.45
7/15/20245,870,000 shares $105.19 million -7.4%N/A9.5 $17.92
6/30/20246,340,000 shares $106.39 million +12.8%N/A10.5 $16.78
6/15/20245,620,000 shares $107.90 million +6.8%N/A9.8 $19.20
5/31/20245,260,000 shares $69.96 million +17.7%N/A15.5 $13.30
5/15/20244,470,000 shares $61.60 million +0.9%N/A13.7 $13.78
4/30/20244,430,000 shares $61.22 million +5.5%N/A12.7 $13.82
4/15/20244,200,000 shares $63.42 million +0.2%N/A11.5 $15.10
3/31/20244,190,000 shares $62.85 million -1.4%N/A12.6 $15.00
3/15/20244,250,000 shares $61.46 million +8.1%N/A12.4 $14.46
2/29/20243,930,000 shares $72.04 million -2.0%N/A12.7 $18.33
2/15/20244,010,000 shares $75.39 million +23.0%N/A13.2 $18.80
1/31/20243,260,000 shares $51.18 million -3.8%N/A11 $15.70
1/15/20243,390,000 shares $49.46 million -4.5%N/A12.9 $14.59
12/31/20233,550,000 shares $53.25 million +15.6%N/A13.5 $15.00
12/15/20233,070,000 shares $46.05 million +5.1%N/A11.3 $15.00
11/30/20232,920,000 shares $38.51 million +3.2%N/A12.4 $13.19
11/15/20232,830,000 shares $32.77 million +23.6%N/A11.4 $11.58
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants (Ad)

Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.

Get the name of Buffett’s likely gold target here
10/31/20232,290,000 shares $25.67 million +39.6%N/A7.9 $11.21
10/15/20231,640,000 shares $21.48 million +14.7%N/A2.6 $13.10
9/30/20231,430,000 shares $20.03 million +10.9%N/A2.3 $14.01
9/15/20231,290,000 shares $20.52 million -8.5%N/A2.1 $15.91
8/31/20231,410,000 shares $24.65 million -15.1%N/A2.2 $17.48
8/15/20231,660,000 shares $37.12 million +5.7%N/A2.7 $22.36
7/31/20231,570,000 shares $34.01 million +55.5%N/A2.8 $21.66
7/15/20231,010,000 shares $9.28 million +11.1%5.1%4 $9.19
6/30/2023909,100 shares $9.41 million +38.5%4.6%3.8 $10.35
6/15/2023656,300 shares $8.07 million -23.0%3.3%2.7 $12.29
5/31/2023852,100 shares $8.44 million -9.8%4.3%4.6 $9.90
5/15/2023944,700 shares $11.16 million +29.3%4.8%5.4 $11.81
4/30/2023730,500 shares $8.47 million -1.8%3.7%4.3 $11.59
4/15/2023743,700 shares $7.16 million +16.3%3.8%5.8 $9.63
3/31/2023639,500 shares $5.91 million +2.3%3.3%5.6 $9.24
3/15/2023625,300 shares $6.02 million +5.5%3.3%6.3 $9.63
2/28/2023592,900 shares $6.11 million +2.8%3.1%6.7 $10.30
2/15/2023576,700 shares $5.29 million +1.2%3.0%6.4 $9.17
1/31/2023569,700 shares $5.92 million +0.0%3.0%6.6 $10.39
1/15/2023569,600 shares $4.88 million -15.2%2.9%7.7 $8.56
12/30/2022671,700 shares $5.96 million -0.2%3.5%8.9 $8.87
12/15/2022673,000 shares $5.32 million +0.1%3.5%10.2 $7.91
11/30/2022672,600 shares $5.76 million -1.0%3.5%10.3 $8.57
11/15/2022679,700 shares $6.17 million -9.5%3.5%10.5 $9.08
10/31/2022751,100 shares $8.90 million -31.7%3.9%13 $11.85
10/15/20221,100,000 shares $12.65 million -20.3%5.8%19.5 $11.50
9/30/20221,380,000 shares $11.48 million -3.5%7.2%25.6 $8.32
9/15/20221,430,000 shares $13.46 million +1.4%7.5%15 $9.41
8/31/20221,410,000 shares $10.50 million -3.4%7.3%13 $7.45
8/15/20221,460,000 shares $12.64 million -0.7%7.6%10.3 $8.66
7/31/20221,470,000 shares $11.52 million -3.3%7.7%8.9 $7.84
7/15/20221,520,000 shares $13.77 million -10.6%7.9%8.4 $9.06
6/30/20221,700,000 shares $13.92 million -22.0%8.9%8.7 $8.19
6/15/20222,180,000 shares $14.72 million -10.7%11.4%10.6 $6.75
5/31/20222,440,000 shares $12.98 million +3.4%12.7%14.6 $5.32
5/15/20222,360,000 shares $14.04 million +3.5%12.3%15.8 $5.95
4/30/20222,280,000 shares $16.10 million +10.1%11.9%17 $7.06
4/15/20222,070,000 shares $16.21 million +4.6%10.8%15.7 $7.83
3/31/20221,980,000 shares $17.25 million -10.0%10.4%14.9 $8.71
3/15/20222,200,000 shares $18.55 million -0.5%11.6%16.7 $8.43
2/28/20222,210,000 shares $13.26 million +11.1%11.7%15.8 $6.00
2/15/20221,990,000 shares $14.23 million No Change10.5%14.5 $7.15
1/31/20221,990,000 shares $15.36 million +7.6%10.5%12.8 $7.72
1/15/20221,850,000 shares $15.71 million +2.2%9.8%12.2 $8.49
12/31/20211,810,000 shares $17.21 million -4.2%9.5%13.8 $9.51
12/15/20211,890,000 shares $19.18 million +3.9%9.9%16.3 $10.15
11/30/20211,820,000 shares $22.00 million +11.0%9.6%17.9 $12.09
11/15/20211,640,000 shares $24.17 million -6.3%8.6%16.8 $14.74
10/29/20211,750,000 shares $30.10 million -0.6%9.2%22.4 $17.20
10/15/20211,760,000 shares $29.96 million -4.9%9.3%20.8 $17.02
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants (Ad)

Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.

Get the name of Buffett’s likely gold target here
9/30/20211,850,000 shares $31.12 million -10.2%9.8%16.5 $16.82
9/15/20212,060,000 shares $31.37 million -6.8%10.9%16.1 $15.23
8/31/20212,210,000 shares $38.94 million -0.5%11.7%16.3 $17.62
8/13/20212,220,000 shares $33.59 million +7.8%11.7%16.1 $15.13
7/30/20212,060,000 shares $31.93 million -1.4%10.9%13.8 $15.50
7/15/20212,090,000 shares $32.19 million -1.9%11.1%14.8 $15.40
6/30/20212,130,000 shares $32.53 million -6.2%11.3%16.1 $15.27
6/15/20212,270,000 shares $38.79 million -7.4%12.0%17.4 $17.09
5/28/20212,450,000 shares $43.17 million +5.2%13.0%16.2 $17.62
5/14/20212,330,000 shares $35.84 million -0.4%12.3%13 $15.38
4/30/20212,340,000 shares $47.20 million -1.3%12.4%12.9 $20.17
4/15/20212,370,000 shares $41.78 million +1.7%12.5%12 $17.63
3/31/20212,330,000 shares $43.15 million -4.9%12.3%11.2 $18.52
3/15/20212,450,000 shares $48.00 million -11.2%12.9%11.1 $19.59
2/26/20212,760,000 shares $55.89 million +1.5%14.7%13.6 $20.25
2/12/20212,720,000 shares $70.94 million +3.8%14.5%14.8 $26.08
1/29/20212,620,000 shares $58.61 million -0.8%13.9%14.6 $22.37
1/15/20212,640,000 shares $55.26 million -1.9%14.0%15.3 $20.93
12/31/20202,690,000 shares $48.66 million +8.9%14.3%17.4 $18.09
12/15/20202,470,000 shares $45.97 million -9.5%13.1%17.9 $18.61
11/30/20202,730,000 shares $55.97 million +2.6%14.4%21.2 $20.50
10/30/20203,010,000 shares $69.20 million -3.8%16.0%20.1 $22.99
10/15/20203,130,000 shares $70.77 million -1.6%16.6%20.5 $22.61
9/30/20203,180,000 shares $61.34 million -0.6%16.9%20.5 $19.29
9/15/20203,200,000 shares $70.43 million +2.9%17.0%20.1 $22.01
8/31/20203,110,000 shares $78.03 million -0.6%16.5%19.7 $25.09
8/14/20203,130,000 shares $71.83 million +2.3%16.6%21 $22.95
7/31/20203,060,000 shares $67.60 million +2.3%17.0%18.9 $22.09
7/15/20202,990,000 shares $70.89 million +5.7%16.7%15.8 $23.71

URGN Short Interest - Frequently Asked Questions

What is Urogen Pharma's current short interest?

Short interest is the volume of Urogen Pharma shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 18,490,000 shares of URGN short. 42.26% of Urogen Pharma's shares are currently sold short. Learn More on Urogen Pharma's current short interest.

What is a good short interest ratio for Urogen Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. URGN shares currently have a short interest ratio of 3.0. Learn More on Urogen Pharma's short interest ratio.

Which institutional investors are shorting Urogen Pharma?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Urogen Pharma: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Urogen Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 42.26% of Urogen Pharma's floating shares are currently sold short.

Is Urogen Pharma's short interest increasing or decreasing?

Urogen Pharma saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 18,490,000 shares, an increase of 201.6% from the previous total of 6,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Urogen Pharma's short interest compare to its competitors?

42.26% of Urogen Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Urogen Pharma: Arrowhead Pharmaceuticals, Inc. (9.55%), Bausch Health Cos Inc. (2.86%), NewAmsterdam Pharma Company N.V. (11.06%), Apellis Pharmaceuticals, Inc. (22.25%), Twist Bioscience Corporation (0.05%), Recursion Pharmaceuticals, Inc. (35.52%), Agios Pharmaceuticals, Inc. (6.83%), Denali Therapeutics Inc. (9.91%), Beam Therapeutics Inc. (24.82%), Kiniksa Pharmaceuticals International, plc (6.10%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Urogen Pharma stock?

Short selling URGN is an investing strategy that aims to generate trading profit from Urogen Pharma as its price is falling. URGN shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Urogen Pharma?

A short squeeze for Urogen Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of URGN, which in turn drives the price of the stock up even further.

How often is Urogen Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including URGN, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:URGN) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners